Bioanalytical Systems, Inc. Ranked One of America's Top 100 Fastest-Growing Small Companies by Fortune Small Business.Business Editors/Health/Medical Writers BIOWIRE2K WEST LAFAYETTE West Lafayette, city (1990 pop. 25,907), Tippecanoe co., W Ind., a suburb of Lafayette, on the Wabash River; inc. 1924. A primarily residential city, it is the seat of Purdue Univ. , Ind.--(BUSINESS WIRE)--July 7, 2003 Bioanalytical Systems, Inc. (Nasdaq:BASI) today announced that it has been named to the Fortune Small Business 100 -- America's Fastest-Growing Small Companies. Fortune Small Business selected public companies that trade on the major exchanges with $200 million or less in annual revenue and ranked these by earnings growth, revenue growth and stock performance over the past three years. Those rankings were averaged to create the final order for the top 100 companies. "Naturally, we are extremely pleased to be recognized by Fortune Small Business as one of America's 100 Fastest-Growing Small Companies," said Peter T. Kissinger, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BASi. "With the acquisition of PharmaKinetics Laboratories, Inc. in Baltimore last week and LC Resources, Inc. in Oregon earlier this year, we are poised for future growth. We continue to add shareholder value through higher margin contract development services, including pre-clinical and clinical research, and through our research equipment business, principally the Culex Culex /Cu·lex/ (ku´leks) a genus of mosquitoes found throughout the world, many species of which are vectors of disease-producing organisms. Cu·lex n. Automated au·to·mate v. au·to·mat·ed, au·to·mat·ing, au·to·mates v.tr. 1. To convert to automatic operation: automate a factory. 2. Blood Sampling system." In business for nearly 30 years, BASi is a pharmaceutical development company that provides contract research services and analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. systems to the world's leading pharmaceutical, drug development and medical device companies. The company focuses on developing innovative services and products that increase efficiency and reduce costs associated with taking new drugs to market. Visit www.bioanalytical.com and www.culex.net for more about BASi. This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks Operating risk The inherent or fundamental risk of a firm, without regard to financial risk. The risk that is created by operating leverage. Also called business risk. detailed in the company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion